BROAD-SPECTRUM IN-VIVO EFFECTIVE SUPERANTIGEN TOXIN ANTAGONISTS BASED ON THE INTERACTION BETWEEN CD28 AND THE SUPERANTIGEN AND USES THEREOF - Patent 1492808

(19)

(11)

EP 1 492 808 A2

(12)

(88)	Date of publication A3:
	18.12.2003

(43)	Date of publication:
	05.01.2005 Bulletin 2005/01

(21)	Application number: 03715301.2

(22)	Date of filing: 03.04.2003

(51)	International Patent Classification (IPC)⁷: C07K 7/08, C07K 7/06, A61K 38/00, G01N 33/53, G01N 33/569, C07K 14/705

(86)	International application number:
	PCT/IL2003/000278

(87)	International publication number:
	WO 2003/084995 (16.10.2003 Gazette 2003/42)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

04.04.2002 IL 14899302

(71)	Applicant: YISSUM RESEARCH DEVELOPMENT COMPANYOF THE HEBREW UNIVERSITY OF JERUSALEM
	91390 Jerusalem (IL)

(72)	Inventors:
	KAEMPFER, Raymond 93707 Jerusalem (IL) ARAD, Gila 90805 Mevasseret Zion (IL)

(74)	Representative: Bentham, Andrew
	J.A. Kemp & Co.14 South SquareGray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(54)	BROAD-SPECTRUM IN-VIVO EFFECTIVE SUPERANTIGEN TOXIN ANTAGONISTS BASED ON THE INTERACTION BETWEEN CD28 AND THE SUPERANTIGEN AND USES THEREOF